Breakthrough RNA-Based Anti-Cancer Immunotherapy Treatments Being Developed by Global Consortium led by the Hadassah Cancer Research Institute
- Monday, September 19, 2022, 7:00
- Finance
- Add a comment
JERUSALEM, Sept. 19, 2022 /PRNewswire/ — The Hadassah Cancer Research Institute (HCRI) at the Hadassah University Medical Center in Jerusalem, announced today that it is leading CancerRNA (www.cancerna.info), a global consortium that aims to apply RNA-based therapeutics to successfully…
About the Author
adminasapcorp has written 42190 stories on this site.